Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 3, 2023

Monarch Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?

MONARCH PHARMS has twenty-two approved drugs.

Summary for Monarch Pharms

US Patents:	0
Tradenames:	17
Ingredients:	14
NDAs:	22

Drugs and US Patents for Monarch Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Monarch Pharms	CORTISPORIN	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OPHTHALMIC	050169-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	PEDIOTIC	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	062822-001	Sep 29, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	MENEST	estrogens, esterified	TABLET;ORAL	084950-001	Approved Prior to Jan 1, 1982		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	KEMADRIN	procyclidine hydrochloride	TABLET;ORAL	009818-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	SEPTRA	sulfamethoxazole; trimethoprim	INJECTABLE;INJECTION	018452-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	MENEST	estrogens, esterified	TABLET;ORAL	084948-001	Approved Prior to Jan 1, 1982		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Monarch Pharms

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Monarch Pharms	SEPTRA DS	sulfamethoxazole; trimethoprim	TABLET;ORAL	017376-002	Approved Prior to Jan 1, 1982	4,209,513	⤷ Try a Trial
Monarch Pharms	QUIBRON-T/SR	theophylline	TABLET, EXTENDED RELEASE;ORAL	087563-001	Jun 21, 1983	4,465,660	⤷ Try a Trial
Monarch Pharms	SEPTRA	sulfamethoxazole; trimethoprim	TABLET;ORAL	017376-001	Approved Prior to Jan 1, 1982	4,209,513	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Monarch Pharms

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

McKesson

Boehringer Ingelheim

Medtronic

Express Scripts

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.